Chronic Schistosoma Japonicum Infection Reduces Immune Response to Vaccine Against Hepatitis B in Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2012 Dec 29

PMID 23272112

Citations 21

Authors

Lin Chen

Wen-Qi Liu

Jia-Hui Lei

Fei Guan

Man-jun Li

Wen-jian Song

Yong-Long Li

Ting Wang

Affiliations

Soon will be listed here.

Abstract

Background: Hepatitis B and schistosomiasis are most prevalent in Africa and Asia, and co-infections of both are frequent in these areas. The immunomodulation reported to be induced by schistosome infections might restrict immune control of hepatitis B virus (HBV) leading to more severe viral infection. Vaccination is the most effective measure to control and prevent HBV infection, but there is evidence for a reduced immune response to the vaccine in patients with chronic schistosomiasis japonica.

Methodology/principal Findings: In this paper, we demonstrate in a mouse model that a chronic Schistosoma japonicum infection can inhibit the immune response to hepatitis B vaccine (HBV vaccine) and lead to lower production of anti-HBs antibodies, interferon-γ (IFN-γ) and interleukin-2 (IL-2). After deworming with Praziquantel (PZQ), the level of anti-HBs antibodies gradually increased and the Th2-biased profile slowly tapered. At 16 weeks after deworming, the levels of anti-HBs antibodies and Th1/Th2 cytokines returned to the normal levels.

Conclusions/significance: The results suggest that the preexisting Th2-dominated immune profile in the host infected with the parasite may down-regulate levels of anti-HBs antibodies and Th1 cytokines. To improve the efficacy of HBV vaccination in schistosome infected humans it may be valuable to treat them with praziquantel (PZQ) some time prior to HBV vaccination.

Citing Articles

Application of microphysiological systems to unravel the mechanisms of schistosomiasis egg extravasation.

Alfred M, Ochola L, Okeyo K, Bae E, Ogongo P, Odongo D Front Cell Infect Microbiol. 2025; 15:1521265.

PMID: 40041145 PMC: 11876127. DOI: 10.3389/fcimb.2025.1521265.

COVID-19 vaccination survey and anti-SARS-CoV-2 IgG responses in a human cohort from -endemic villages in Mayuge District, Uganda: a cross-sectional study.

Niu M, Mu Y, Adriko M, Candia R, Jones M, McManus D Front Public Health. 2024; 12:1437063.

PMID: 39624416 PMC: 11609215. DOI: 10.3389/fpubh.2024.1437063.

Antibody response after feline panleukopenia virus vaccination in kittens with and without intestinal parasites.

Weidinger A, Hartmann K, Barutzki D, Truyen U, Abd El Wahed A, Zablotski Y J Feline Med Surg. 2024; 26(8):1098612X241264731.

PMID: 39212546 PMC: 11418612. DOI: 10.1177/1098612X241264731.

Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.

Desai P, Karl C, Ying B, Liang C, Garcia-Salum T, Santana A bioRxiv. 2024; .

PMID: 38293221 PMC: 10827110. DOI: 10.1101/2024.01.14.575588.

A New Role for Old Friends: Effects of Helminth Infections on Vaccine Efficacy.

Zhu F, Liu W, Liu T, Shi L, Zheng W, Guan F Pathogens. 2022; 11(10).

PMID: 36297220 PMC: 9608950. DOI: 10.3390/pathogens11101163.

References

McClary H, Koch R, Chisari F, Guidotti L . Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice. J Exp Med. 2000; 192(2):289-94. PMC: 2193253. DOI: 10.1084/jem.192.2.289. View

van Riet E, Hartgers F, Yazdanbakhsh M . Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology. 2007; 212(6):475-90. DOI: 10.1016/j.imbio.2007.03.009. View

Stewart G, Boussinesq M, Coulson T, Elson L, Nutman T, Bradley J . Onchocerciasis modulates the immune response to mycobacterial antigens. Clin Exp Immunol. 1999; 117(3):517-23. PMC: 1905356. DOI: 10.1046/j.1365-2249.1999.01015.x. View

Bundy D, Sher A, Michael E . Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases?. Parasitol Today. 2000; 16(7):273-4. DOI: 10.1016/s0169-4758(00)01689-6. View

Zanetti A, Van Damme P, Shouval D . The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008; 26(49):6266-73. DOI: 10.1016/j.vaccine.2008.09.056. View

Bentwich Z, Kalinkovich A, Weisman Z, Borkow G, Beyers N, Beyers A . Can eradication of helminthic infections change the face of AIDS and tuberculosis?. Immunol Today. 1999; 20(11):485-7. DOI: 10.1016/s0167-5699(99)01499-1. View

King C, Dickman K, Tisch D . Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet. 2005; 365(9470):1561-9. DOI: 10.1016/S0140-6736(05)66457-4. View

Borkow G, Leng Q, Weisman Z, Stein M, Galai N, Kalinkovich A . Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J Clin Invest. 2000; 106(8):1053-60. PMC: 314342. DOI: 10.1172/JCI10182. View

Sabin E, Araujo M, Carvalho E, Pearce E . Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. J Infect Dis. 1996; 173(1):269-72. DOI: 10.1093/infdis/173.1.269. View

10.

Cooper P, Chico M, Losonsky G, Sandoval C, Espinel I, Sridhara R . Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR. J Infect Dis. 2000; 182(4):1199-206. DOI: 10.1086/315837. View

11.

Eren R, Lubin I, Terkieltaub D, Ben-Moshe O, Zauberman A, UHLMANN R . Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology. 1998; 93(2):154-61. PMC: 1364173. DOI: 10.1046/j.1365-2567.1998.00426.x. View

12.

Song W, Cheng Y, Liu L, Kong Z, Hu S, Liu K . [Impact of chronic schistosomiasis japonica on the protective immunity induced by vaccine against hepatitis B virus]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2005; 23(3):163-5. View

13.

GHAFFAR Y, Kamel M, Abdel Wahab M, Dorgham L, Saleh M, el Deeb A . Hepatitis B vaccination in children infected with Schistosoma mansoni: correlation with ultrasonographic data. Am J Trop Med Hyg. 1990; 43(5):516-9. DOI: 10.4269/ajtmh.1990.43.516. View

14.

Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, Britton S . Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine. 2005; 23(11):1326-34. DOI: 10.1016/j.vaccine.2004.09.038. View

15.

John T, Jayabal P . Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol. 1972; 96(4):263-9. DOI: 10.1093/oxfordjournals.aje.a121457. View

16.

Cioli D, Pica-Mattoccia L . Praziquantel. Parasitol Res. 2003; 90 Supp 1:S3-9. DOI: 10.1007/s00436-002-0751-z. View

17.

Lanata C, Midthun K, Black R, Butron B, Huapaya A, Penny M . Safety, immunogenicity, and protective efficacy of one and three doses of the tetravalent rhesus rotavirus vaccine in infants in Lima, Peru. J Infect Dis. 1996; 174(2):268-75. DOI: 10.1093/infdis/174.2.268. View

18.

GHAFFAR Y, Kamel M, Bahnasy R, Strickland G . Response to hepatitis B vaccine in infants born to mothers with schistosomiasis. Lancet. 1989; 2(8657):272. DOI: 10.1016/s0140-6736(89)90453-4. View

19.

Collins H, Kaufmann S . The many faces of host responses to tuberculosis. Immunology. 2001; 103(1):1-9. PMC: 1783212. DOI: 10.1046/j.1365-2567.2001.01236.x. View

20.

Muniz-Junqueira M, Tavares-Neto J, Prata A, Tosta C . Antibody response to Salmonella typhi in human schistosomiasis mansoni. Rev Soc Bras Med Trop. 1996; 29(5):441-5. DOI: 10.1590/s0037-86821996000500006. View